- Docket No.
- 1:25-cv-04212
- District Court
- Maryland — Northern
Goal
- Block enforcement of an agency action
- Compel agency action
- Declaration that an agency action is unlawful
- Vacate agency action
Issues
Litigation Content
Why This Matters:
Why This Matters
The plaintiffs argue that the Inflation Reduction Act’s Medicare drug negotiation process violates the Administrative Procedure Act. Medicare’s authority to negotiate the price of certain single-source, high-priced drugs is estimated to result in substantial savings for Medicare beneficiaries and the federal government.
Potential Impact:
Potential Impact
Successful challenges to Medicare’s negotiation authority would negate savings to Medicare beneficiaries and taxpayers and could severely restrict federal regulatory authority in the health care arena.
17 Major Filings
- PLAINTIFFS' NOTICE OF APPEAL (Aug 21, 2026)
- ORDER ON MOTION TO DISMISS AND MOTIONS FOR SUMMARY JUDGMENT (Aug 19, 2026)
- DEFENDANTS' NOTICE OF SUPPLEMENTAL AUTHORITY (Aug 18, 2026)
- PLAINTIFFS' RESPONSE TO NOTICE OF SUPPLEMENTAL AUTHORITY (Jul 16, 2026)
- DEFENDANTS' NOTICE OF SUPPLEMENTAL AUTHORITY (Jul 13, 2026)
- SCHEDULING ORDER (Jun 26, 2026)
- DEFENDANTS' REPLY RE: MOTION TO DISMISS (Jun 11, 2026)
- SCHEDULING ORDER (May 21, 2026)
- PLAINTIFFS' RESPONSE TO MOTION FOR EXTENSION OF TIME (May 21, 2026)
- DEFENDANTS' MOTION FOR EXTENSION OF TIME (May 20, 2026)
- PLAINTIFFS' REPLY RE: MOTION FOR SUMMARY JUDGMENT (Apr 28, 2026)
- DEFENDANTS' MOTION TO DISMISS (Mar 27, 2026)
- AMICUS BRIEF [BAUSCH HEALTH COMPANIES INC. ET AL.] (Mar 4, 2026)
- PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT (Feb 27, 2026)
- SCHEDULING ORDER (Feb 18, 2026)
- SCHEDULING ORDER (Feb 5, 2026)
- COMPLAINT (Dec 19, 2025)